Wealthfront Advisers LLC Royalty Pharma PLC Transaction History
Wealthfront Advisers LLC
- $34.9 Billion
- Q1 2025
A detailed history of Wealthfront Advisers LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Wealthfront Advisers LLC holds 194,776 shares of RPRX stock, worth $6.57 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
194,776
Previous 188,935
3.09%
Holding current value
$6.57 Million
Previous $4.82 Million
25.81%
% of portfolio
0.02%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding RPRX
# of Institutions
484Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.38 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.24 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$777 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$452 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$411 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...